PATENT CLAIM ANALYSIS

Application Number: 15873416
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["514", "001100"]

Abstract:
The disclosure provides compositions and methods for counteracting the effects of direct activated Factor X (FXa) inhibitors in a subject by administering a variant of FXa.

Claim (Index 24):
The method of  claim 22 , wherein the International Normalized Ratio (INR) in said subject is about 4.0, 3.9, 3.8, 3.7, 3.6, 3.5, 3.4, 3.3, 3.2, 3.1, 3.0, 2.9, 2.8, 2.7, 2.6, 2.5, 2.4, 2.3, 2.2, 2.1, 2.0, 1.9, 1.8, 1.7, 1.6, 1.5, 1.4, 1.3, 1.2, 1.1, 1.0, 0.9, 0.8, or 0.7.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 86.0
- Lexical Diversity: 1.11538
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12616735', '13414499', '13889014', '12239651', '13591098']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8017103479961715
- 35 USC 102 Novelty (BERT): 0.5319192357310158
- Combined Prediction Score: 0.7747312367696558
- Mean Citation Score: 318.84791800000005
- Max Citation Score: 322.3307200000001
- Similarity Product: 146.51442910061365

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test